Here's Why Aristotle Atlantic's Core Equity Composite Sold Abbott Laboratories (ABT) [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
A copy of the letter can be downloaded here . In the second quarter, the U.S. equity market reached a record high. Aristotle Atlantic's Core Equity strategy returned 5.61% gross of fees (5.51% net of fees) in the quarter outperforming the S&P 500 Index's 4.28% total return. The relative outperformance was due to security selection. Security selection in Information Technology and Health Care contributed the most to relative performance while Consumer Staples and Consumer Discretionary detracted. In addition, you can check the fund's top 5 holdings to determine its best picks for 2024. Aristotle Atlantic Core Equity Strategy highlighted stocks like Abbott Laboratories (NYSE: ABT ) in the second quarter 2024 investor letter. Abbott Laboratories (NYSE:ABT) engages in the discovery, development, manufacturing, and sale of healthcare products. On July 23, 2024, Abbott Laboratories (NYSE:ABT) stock closed at $103.92 per share. One-month return of Abbott Laboratories (NYSE:ABT) was -0.92%,
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott's Lingo CGM System Gains U.S. Availability: Stock to Gain? [Yahoo! Finance]Yahoo! Finance
- FDA hits Abbott FreeStyle Libre 3 recall with Class I tag [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories Recalls Some Sensors For Its Popular FreeStyle Libre 3 Glucose Monitoring System [Yahoo! Finance]Yahoo! Finance
- Abbott launches its first over-the-counter continuous glucose monitor in the U.S. [CNBC]CNBC
- Abbott's Lingo™ Continuous Glucose Monitor for Health and Wellness Now Available in the U.S.PR Newswire
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 9/4/24 - Form 4
- 9/4/24 - Form 4
- 9/4/24 - Form 144
- ABT's page on the SEC website